236 related articles for article (PubMed ID: 21750559)
1. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation.
Spagnuolo C; Cerella C; Russo M; Chateauvieux S; Diederich M; Russo GL
Br J Cancer; 2011 Jul; 105(2):221-30. PubMed ID: 21750559
[TBL] [Abstract][Full Text] [Related]
2. ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.
Russo M; Spagnuolo C; Volpe S; Tedesco I; Bilotto S; Russo GL
Biochem Pharmacol; 2013 Apr; 85(7):927-36. PubMed ID: 23353698
[TBL] [Abstract][Full Text] [Related]
3. Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients.
Russo M; Spagnuolo C; Volpe S; Mupo A; Tedesco I; Russo GL
Br J Cancer; 2010 Aug; 103(5):642-8. PubMed ID: 20648016
[TBL] [Abstract][Full Text] [Related]
4. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.
Jacquemin G; Granci V; Gallouet AS; Lalaoui N; Morlé A; Iessi E; Morizot A; Garrido C; Guillaudeux T; Micheau O
Haematologica; 2012 Jan; 97(1):38-46. PubMed ID: 21933852
[TBL] [Abstract][Full Text] [Related]
5. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax.
Cheng S; Gao N; Zhang Z; Chen G; Budhraja A; Ke Z; Son YO; Wang X; Luo J; Shi X
Clin Cancer Res; 2010 Dec; 16(23):5679-91. PubMed ID: 21138867
[TBL] [Abstract][Full Text] [Related]
6. The pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia.
Russo GL; Russo M; Spagnuolo C
Food Funct; 2014 Oct; 5(10):2393-401. PubMed ID: 25096193
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells.
Ashofteh N; Amini R; Molaee N; Karami H; Baazm M
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2191-2198. PubMed ID: 34319043
[TBL] [Abstract][Full Text] [Related]
8. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.
Balakrishnan K; Burger JA; Wierda WG; Gandhi V
Blood; 2009 Jan; 113(1):149-53. PubMed ID: 18836097
[TBL] [Abstract][Full Text] [Related]
9. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
10. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
[TBL] [Abstract][Full Text] [Related]
11. Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.
Schulze-Bergkamen H; Ehrenberg R; Hickmann L; Vick B; Urbanik T; Schimanski CC; Berger MR; Schad A; Weber A; Heeger S; Galle PR; Moehler M
World J Gastroenterol; 2008 Jun; 14(24):3829-40. PubMed ID: 18609706
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101
[TBL] [Abstract][Full Text] [Related]
13. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
Rosato RR; Almenara JA; Coe S; Grant S
Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
[TBL] [Abstract][Full Text] [Related]
14. Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.
Chen R; Guo L; Chen Y; Jiang Y; Wierda WG; Plunkett W
Blood; 2011 Jan; 117(1):156-64. PubMed ID: 20971952
[TBL] [Abstract][Full Text] [Related]
15. Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia.
Spagnuolo C; Russo M; Bilotto S; Tedesco I; Laratta B; Russo GL
Ann N Y Acad Sci; 2012 Jul; 1259():95-103. PubMed ID: 22758641
[TBL] [Abstract][Full Text] [Related]
16. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
17. BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199.
Bojarczuk K; Sasi BK; Gobessi S; Innocenti I; Pozzato G; Laurenti L; Efremov DG
Blood; 2016 Jun; 127(25):3192-201. PubMed ID: 27095788
[TBL] [Abstract][Full Text] [Related]
18. c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells.
Allen JC; Talab F; Zuzel M; Lin K; Slupsky JR
Blood; 2011 Feb; 117(8):2414-22. PubMed ID: 21220745
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]